Evidence map›Paper›PMID 25560242›Full record

ArticleRedox biology2015

"Twin peaks": searching for 4-hydroxynonenal urinary metabolites after oral administration in rats.

Julia Keller, Maryse Baradat, Isabelle Jouanin, Laurent Debrauwer, Françoise Guéraud

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Julia KellerUMR 1331 Toxalim, INRA, INP, UPS, Team 9 "Prevention, Promotion of Carcinogenesis by Food", BP 93173, 180 chemin de Tournefeuille, 31027 Toulouse CEDEX, France.
Maryse BaradatUMR 1331 Toxalim, INRA, INP, UPS, Team 9 "Prevention, Promotion of Carcinogenesis by Food", BP 93173, 180 chemin de Tournefeuille, 31027 Toulouse CEDEX, France.
Isabelle JouaninUMR 1331 Toxalim, INRA, INP, UPS, Axiom Platform, BP 93173, 180 chemin de Tournefeuille, 31027 Toulouse CEDEX, France.
Laurent DebrauwerUMR 1331 Toxalim, INRA, INP, UPS, Axiom Platform, BP 93173, 180 chemin de Tournefeuille, 31027 Toulouse CEDEX, France.
Françoise GuéraudUMR 1331 Toxalim, INRA, INP, UPS, Team 9 "Prevention, Promotion of Carcinogenesis by Food", BP 93173, 180 chemin de Tournefeuille, 31027 Toulouse CEDEX, France. Electronic address: fgueraud@toulouse.inra.fr.
Toxalim Research Centre in Food Toxicology · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

4-Hydroxynonenal (HNE) is a cytotoxic and genotoxic lipid oxidation secondary product which is formed endogenously upon peroxidation of cellular n-6 fatty acids. However, it can also be formed in food or during digestion, upon peroxidation of dietary lipids. Several studies have evidenced that we are exposed through food to significant concentrations of HNE that could pose a toxicological concern. It is then of importance to known how HNE is metabolized after oral administration. Although its metabolism has been studied after intravenous administration in order to mimick endogenous formation, its in vivo fate after oral administration had never been studied. In order to identify and quantify urinary HNE metabolites after oral administration in rats, radioactive and stable isotopes of HNE were used and urine was analyzed by radio-chromatography (radio-HPLC) and chromatography coupled with High Resolution Mass Spectrometry (HPLC-HRMS). Radioactivity distribution revealed that 48% of the administered radioactivity was excreted into urine and 15% into feces after 24h, while 3% were measured in intestinal contents and 2% in major organs, mostly in the liver. Urinary radio-HPLC profiles revealed 22 major peaks accounting for 88% of the urinary radioactivity. For identification purpose, HNE and its stable isotope [1,2-(13)C]-HNE were given at equimolar dose to be able to univocally identify HNE metabolites by tracking twin peaks on HPLC-HRMS spectra. The major peak was identified as 9-hydroxy-nonenoic acid (27% of the urinary radioactivity) followed by classical HNE mercapturic acid derivatives (the mercapturic acid conjugate of di-hydroxynonane (DHN-MA), the mercapturic acid conjugate of 4-hydroxynonenoic acid (HNA-MA) in its opened and lactone form) and by metabolites that are oxidized in the terminal position. New urinary metabolites as thiomethyl and glucuronide conjugates were also evidenced. Some analyses were also performed on feces and gastro-intestinal contents, revealing the presence of tritiated water that could originate from beta-oxidation reactions.

Indexed as

Lipid PeroxidationAcetylcysteineAdministration, OralAldehydesAnimalsChromatography, High Pressure LiquidDietary Fats, UnsaturatedFatty Acids, Omega-6Fatty Acids, UnsaturatedGlutathioneHydroxy AcidsLiverOxidation-ReductionRats4-hydroxy-2-nonenal4-hydroxynonenoic acidAcetylcysteineAldehydesDietary Fats, UnsaturatedFatty Acids, Omega-6Fatty Acids, UnsaturatedGlutathioneHydroxy Acids4-HydroxynonenalHRMSIsotope trackingLipoperoxidationMetabolism

Identifiers

PMID25560242
PMCPMC4309853
OpenAlexW2047164448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.